Insight into Practice, Care into Outcomes
The UK–China Private Healthcare Summit
Treatment data and health surveillance usually sit in separate systems. MEDii holds them together and reads them together, so that small things are caught early rather than simply filed. A doctor-led private hospital in central London, operating across both the UK and Chinese markets.
Doctor-led private hospital in central London, founded 2017 · UK CQC medical licence · UKAS-accredited laboratory · MRCP and FRCS doctors · UK work-visa issuing body · Designated PCR testing centre for the Chinese Embassy in the UK · Medical-certificate issuer recognised by the UK Foreign Office.
We are not observing the shift to data-driven care. We are running it.
Three opening addresses, then four ten-minute contributions on systems already in live clinical use.
Minister & Chief of the Economic and Commercial Section, Embassy of the People's Republic of China in the United Kingdom of Great Britain and Northern Ireland.
Lijun Xin joined JD.com in 2012, when the company was still a pure retail business, and spent eight years building out its third-party platform across categories from apparel to healthcare. In July 2019 he was appointed Chief Executive of JD Health with an unusual brief: invest in the health sector ahead of profit, and measure success by patient satisfaction rather than performance metrics.
Under his leadership JD Health became one of the largest digital health platforms in the world — reporting 387 million annual active users, pharmacy operations accounting for more than 15% of China's retail pharmaceutical market, and around 100,000 online consultations a day. Few people anywhere have run AI-supported healthcare delivery at that scale.
Huw Shurmer chairs AXREM, the Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care: the UK trade body through which the diagnostic imaging and radiotherapy industry engages with government, the NHS and the regulator. He also chairs WCIF.
His day role is Strategic and Government Relationship Manager at Fujifilm Healthcare, which places him on both sides of the question this evening is built around. What a manufacturer has to prove before an AI-assisted system is approved, and what a health service has to change before it can use one.
Where is AI genuinely being used in everyday clinical life — and what has it actually changed?
Optional reading: the room, the exhibition and past editions.
Attendance is by invitation and deliberately senior — which is why presentations here tend to turn into conversations that carry on afterwards.
Officials and parliamentarians working on health innovation, life sciences and the regulation of clinical AI.
UK private hospitals, healthcare groups and local healthcare facilities — those responsible for what actually gets deployed.
Senior representatives of Chinese healthcare, technology and investment organisations active in or entering the UK market.
Consultant-level clinicians, health-technology founders and investors working across both healthcare systems.
The talks are only part of the evening. Two exhibition zones run alongside them throughout, open from the reception at 18:30 and through networking afterwards.
Commercial and domestic robots on display, from service and assistive machines to the systems now appearing at the edge of everyday care.
Art and craft made entirely by hand, shown deliberately in a room otherwise given over to machine intelligence. A quiet argument about what we are choosing to keep human.
The inaugural Summit, convened to open a practical channel between UK and Chinese private healthcare.
Watch the 2018 SummitThe second edition, which established the Summit's format and its home at the British Library.
Watch the 2025 SummitReturning to the British Library, focused for the first time entirely on the applied use of AI in healthcare delivery.